Advertisement

Journal of Bone and Mineral Metabolism

, Volume 37, Issue 1, pp 28–35 | Cite as

Single-dose local administration of parathyroid hormone (1–34, PTH) with β-tricalcium phosphate/collagen (β-TCP/COL) enhances bone defect healing in ovariectomized rats

  • Zhou-Shan TaoEmail author
  • Wan-Shu Zhou
  • Xin-Jing Wu
  • Lin Wang
  • Min Yang
  • Jia-Bing Xie
  • Zhu-Jun Xu
  • Guo-Zheng Ding
Original Article

Abstract

Parathyroid hormone (1–34, PTH) combined β-tricalcium phosphate (β-TCP) achieves stable bone regeneration without cell transplantation in previous studies. Recently, with the development of tissue engineering slow release technology, PTH used locally to promote bone defect healing become possible. This study by virtue of collagen with a combination of drugs and has a slow release properties, and investigated bone regeneration by β-TCP/collagen (β-TCP/COL) with the single local administration of PTH. After the creation of a rodent critical-sized femoral metaphyseal bone defect, β-TCP/COL was prepared by mixing sieved granules of β-TCP and atelocollagen for medical use, then β-TCP/COL with dripped PTH solution (1.0 µg) was implanted into the defect of OVX rats until death at 4 and 8 weeks. The defected area in distal femurs of rats was harvested for evaluation by histology, micro-CT, and biomechanics. The results of our study show that single-dose local administration of PTH combined local usage of β-TCP/COL can increase the healing of defects in OVX rats. Furthermore, treatments with single-dose local administration of PTH and β-TCP/COL showed a stronger effect on accelerating the local bone formation than β-TCP/COL used alone. The results from our study demonstrate that combination of single-dose local administration of PTH and β-TCP/COL had an additive effect on local bone formation in osteoporosis rats.

Keywords

Osteoporotic bone β-Tricalcium phosphate/collagen Parathyroid hormone Defect healing Micro-CT 

Notes

Acknowledgements

This study was supported by a grant from the natural science foundation for education department of Anhui Province (Grant no. KJ2017A266).

Compliance with ethical standards

Conflict of interest

All authors have no conflict of interest.

References

  1. 1.
    Ström O, Borgström F, Kanis John A, Compston Juliet, Cooper Cyrus, McCloskey Eugene V, Jönsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6:59–155CrossRefGoogle Scholar
  2. 2.
    Prevention NCDPoO (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA J Am Med Assoc 285:785–795CrossRefGoogle Scholar
  3. 3.
    Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399–428CrossRefGoogle Scholar
  4. 4.
    Reginster JY (2011) Antifracture efficacy of currently available therapies for postmenopausal osteoporosis. Drugs 71:65–78CrossRefGoogle Scholar
  5. 5.
    Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the american society for bone and mineral research. J Bone Miner Res 25:2267–2294CrossRefGoogle Scholar
  6. 6.
    Mccann RM, Colleary G, Geddis C, Clarke SA, Jordan GR, Dickson GR, Marsh D (2008) Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model. J Orthop Res 26:384–393CrossRefGoogle Scholar
  7. 7.
    Hao YJ, Zhang G, Wang YS, Qin L, Hung WY, Leung K, Pei FX (2007) Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats. Bone 41:631–638.  https://doi.org/10.1016/j.bone.2007.06.006 CrossRefGoogle Scholar
  8. 8.
    Tao ZS, Zhou WS, Tu KK, Huang ZL, Zhou Q, Sun T, Lv YX, Cui W, Yang L (2015) The effects of combined human parathyroid hormone (1–34) and simvastatin treatment on osseous integration of hydroxyapatite-coated titanium implants in the femur of ovariectomized rats. Injury 46:2164–2169.  https://doi.org/10.1016/j.injury.2015.08.034 CrossRefGoogle Scholar
  9. 9.
    Tao ZS, Lv YX, Cui W, Huang ZL, Tu KK, Zhou Q, Sun T, Yang L (2016) Effect of teriparatide on repair of femoral metaphyseal defect in ovariectomized rats. Z Gerontol Geriatr 49:423–428CrossRefGoogle Scholar
  10. 10.
    Tao ZS, Zhou WS, Tu KK, Huang ZL, Zhou Q, Sun T, Lv YX, Cui W, Yang L (2015) Effect exerted by teriparatide upon repair function of beta-tricalcium phosphate to ovariectomised rat’s femoral metaphysis defect caused by osteoporosis. Injury 46:2134–2141.  https://doi.org/10.1016/j.injury.2015.07.042 CrossRefGoogle Scholar
  11. 11.
    Zacchetti G, Dayer R, Rizzoli R, Ammann P (2014) Systemic treatment with strontium ranelate accelerates the filling of a bone defect and improves the material level properties of the healing bone. Biomed Res Int 2014:549785.  https://doi.org/10.1155/2014/549785 CrossRefGoogle Scholar
  12. 12.
    Tao ZS, Tu KK, Huang ZL, Zhou Q, Sun T, Xu HM, Zhou YL, Lv YX, Cui W, Yang L (2015) Combined treatment with parathyroid hormone (1–34) and beta-tricalcium phosphate had an additive effect on local bone formation in a rat defect model. Med Biol Eng Comput.  https://doi.org/10.1007/s11517-015-1402-8 Google Scholar
  13. 13.
    Tao ZS, Zhou WS, Tu KK, Huang ZL, Zhou Q, Sun T, Lv YX, Cui W, Yang L (2015) Treatment study of distal femur for parathyroid hormone (1–34) and beta-tricalcium phosphate on bone formation in critical-sized defects in osteopenic rats. J Craniomaxillofac Surg Off Publ Eur Assoc Craniomaxillofac Surg 43:2136–2143.  https://doi.org/10.1016/j.jcms.2015.09.004 Google Scholar
  14. 14.
    Tao ZS, Qiang Z, Tu KK, Huang ZL, Xu HM, Sun T, Lv YX, Cui W, Yang L (2015) Treatment study of distal femur for parathyroid hormone (1–34) and beta-tricalcium phosphate on bone formation in critical size defects in rats. J Biomater Appl 30:484–491.  https://doi.org/10.1177/0885328215592854 CrossRefGoogle Scholar
  15. 15.
    Yu X, Wang L, Jiang X, Rowe D, Wei M (2012) Biomimetic CaP coating incorporated with parathyroid hormone improves the osseointegration of titanium implant. J Mater Sci Mater Med 23:2177–2186CrossRefGoogle Scholar
  16. 16.
    Mohseni M, Jahandideh A, Abedi G, Akbarzadeh A, Hesaraki S (2017) Assessment of tricalcium phosphate/collagen (TCP/collagene)nanocomposite scaffold compared with hydroxyapatite (HA) on healing of segmental femur bone defect in rabbits. Artif Cells Nanomed Biotechnol.  https://doi.org/10.1080/21691401.2017.1324463
  17. 17.
    Tao ZS, Bai BL, He XW, Liu W, Li H, Zhou Q, Sun T, Huang ZL, Tu KK, Lv YX, Cui W, Yang L (2016) A comparative study of strontium-substituted hydroxyapatite coating on implant’s osseointegration for osteopenic rats. Med Biol Eng Comput.  https://doi.org/10.1007/s11517-016-1494-9 Google Scholar
  18. 18.
    Tao ZS, Zhou WS, He XW, Liu W, Bai BL, Zhou Q, Huang ZL, Tu KK, Li H, Sun T, Lv YX, Cui W, Yang L (2016) A comparative study of zinc, magnesium, strontium-incorporated hydroxyapatite-coated titanium implants for osseointegration of osteopenic rats. Mater Sci Eng C Mater Biol Appl 62:226–232.  https://doi.org/10.1016/j.msec.2016.01.034 CrossRefGoogle Scholar
  19. 19.
    Zhang Y, Cheng N, Miron R, Shi B, Cheng X (2012) Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects. Biomaterials 33:6698–6708CrossRefGoogle Scholar
  20. 20.
    Zhang Y, Wu C, Luo T, Li S, Cheng X, Miron RJ (2012) Synthesis and inflammatory response of a novel silk fibroin scaffold containing BMP7 adenovirus for bone regeneration. Bone 51:704–713CrossRefGoogle Scholar
  21. 21.
    Yang N, Cui Y, Tan J, Fu X, Han X, Leng H, Song C (2014) Local injection of a single dose of simvastatin augments osteoporotic bone mass in ovariectomized rats. J Bone Miner Metab 32:252–260.  https://doi.org/10.1007/s00774-013-0496-z CrossRefGoogle Scholar
  22. 22.
    Bone HG, Greenspan SL, Mckeever C, Bell N, Davidson M, Downs RW, Emkey R, Meunier PJ, Miller SS, Mulloy AL (2000) Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. J Clin Endocr Metab 85:720–726Google Scholar
  23. 23.
    Tao ZS, Lv YX, Cui W, Huang ZL, Tu KK, Zhou Q, Sun T, Yang L (2015) Effect of teriparatide on repair of femoral metaphyseal defect in ovariectomized rats. Z Gerontol Geriatr.  https://doi.org/10.1007/s00391-015-0949-1 Google Scholar
  24. 24.
    Comelekoglu U, Bagis S, Yalin S, Ogenler O, Yildiz A, Sahin NO, Oguz I, Hatungil R (2007) Biomechanical evaluation in osteoporosis: ovariectomized rat model. Clin Rheumatol 26:380–384.  https://doi.org/10.1007/s10067-006-0367-2 CrossRefGoogle Scholar
  25. 25.
    Hutmacher DW (2000) Scaffolds in tissue engineering bone and cartilage. Biomaterials 21:2529CrossRefGoogle Scholar
  26. 26.
    Li Q, Wang T, Zhang G, Yu X, Zhang J, Zhou G, Tang Z (2016) A comparative evaluation of the mechanical properties of two calcium phosphate/collagen composite materials and their osteogenic effects on adipose-derived stem cells. Stem Cells Int 1–12.  https://doi.org/10.1155/2016/6409546
  27. 27.
    Dorozhkin SV (2013) Calcium orthophosphates in dentistry. J Mater Sci Mater Med 24:1335CrossRefGoogle Scholar
  28. 28.
    Chevallay B, Herbage D (2000) Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy. Med Biol Eng Comput 38:211–218CrossRefGoogle Scholar
  29. 29.
    Wolf K, Alexander S, Schacht V, Coussens LM, von Andrian UH, Van RJ, Deryugina E, Friedl P (2009) Collagen-based cell migration models in vitro and in vivo. Semin Cell Dev Biol 20:931–941CrossRefGoogle Scholar
  30. 30.
    Kanda N, Matsui K, Kawai T, Edamatsu H, Tanuma Y, Suzuki O, Takahashi T, Kamakura S (2016) Implantation of octacalcium phosphate collagen composites (OCP/Col) after extraction of canine deciduous teeth achieved undisturbed permanent tooth eruption. Arch Oral Biol 72:179CrossRefGoogle Scholar
  31. 31.
    Beaman FD, Bancroft LW, Peterson JJ, Kransdorf MJ (2006) Bone graft materials and synthetic substitutes. Radiol Clin N Am 44:451–461CrossRefGoogle Scholar
  32. 32.
    Meganck JA, Koh AJ, Keller ET (2008) Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation. Bone 42:806–818CrossRefGoogle Scholar
  33. 33.
    Komrakova M, Stuermer EK, Werner C, Wicke M, Kolios L, Sehmisch S, Tezval M, Daub F, Martens T, Witzenhausen P (2010) Effect of human parathyroid hormone hPTH (1–34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone 47:480–492CrossRefGoogle Scholar
  34. 34.
    Andreassen TT, Fledelius C, Ejersted C, Oxlund H (2001) Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop Scand 72:304–307CrossRefGoogle Scholar
  35. 35.
    Nozaka K, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Shimada Y (2008) Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone 42:90–97CrossRefGoogle Scholar
  36. 36.
    Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res 17:2038–2047CrossRefGoogle Scholar

Copyright information

© The Japanese Society for Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Trauma Orthopedics, The First Affiliated Hospital of Wannan Medical CollegeYijishan HospitalWuhuPeople’s Republic of China
  2. 2.Department of Geriatrics, The Second Affiliated Hospital of Wannan Medical CollegeWuhuPeople’s Republic of China

Personalised recommendations